Target intelligence / Profile preview

Cytotoxic T Lymphocyte Response (CTL Response)

Target
CTL Response
Molecular classification
Immune Response
01

Overview

Cytotoxic T lymphocytes (CTLs), also known as cytotoxic T cells, killer T cells, or CD8+ T cells, are a specialized subset of immune cells that play a central role in the adaptive immune response. Their primary function is to identify and destroy infected, cancerous, or otherwise abnormal cells within the body. CTLs recognize antigens presented by MHC class I molecules on target cells and kill target cells bearing specific antigens while sparing neighboring uninfected or healthy cells. Activated CTLs release cytolytic proteins such as perforin and granzymes. Additionally, they can express Fas ligand on their surface; binding to Fas on target cells triggers programmed cell death via apoptosis. Cytotoxic T lymphocytes are crucial for controlling viral infections and eliminating tumorigenic/cancerous cells but are also implicated in autoimmune diseases if they mistakenly attack healthy tissues.

Other names
Cytotoxic T CellKiller T CellCD8+ T CellTC CellCytolytic T Cell
02

Mechanism of action

CTLs recognize and kill target cells through the release of cytolytic proteins (perforin, granzymes) and Fas-FasL interaction, inducing apoptosis.

03

Biological functions

Cell-mediated cytotoxicityAdaptive immune responseElimination of infected cellsElimination of cancerous cellsApoptosis induction
04

Disease associations

Viral infectionsCancerAutoimmune diseases
05

Safety considerations

Cytokine release syndrome (CRS)On-target, off-tumor toxicity in immunotherapyAutoimmunity
06

Interacting drugs

Cancer immunotherapies (e.g., checkpoint inhibitors)

1 more in the full profile.

07

Biomarkers

CD8+ T cell countCTL activation markers (e.g., granzyme B expression)MHC class I expression on target cellsTumor-infiltrating lymphocytes (TILs)

Beyond the preview

Go deeper on Cytotoxic T Lymphocyte Response (CTL Response).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytotoxic T Lymphocyte Response (CTL Response).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call